NCT05869669: RewinD-LB - Clinical Study of Neflamapimod in Patients With Dementia With Lewy Bodies |
|
|
| Active, not recruiting | 2 | 160 | Europe, US | Neflamapimod, VX-745, Placebo | EIP Pharma Inc, National Institute on Aging (NIA), Worldwide Clinical Trials, CervoMed, Inc | Dementia With Lewy Bodies | 08/24 | 03/25 | | |